Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Olanzapine”

351 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 351 results

Post-approval studies (Phase 4)Ended earlyNCT05213143
What this trial is testing

The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine

Who this might be right for
Schizophrenia
Sumitomo Pharma (Suzhou) Co., Ltd. 13
Not applicableEnded earlyNCT01625923
What this trial is testing

A Pilot Study on the Efficacy and Safety of Olanzapine in Gastroparesis

Who this might be right for
Idiopathic Gastroparesis
University of Michigan 3
Large-scale testing (Phase 3)Looking for participantsNCT06200168
What this trial is testing

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

Who this might be right for
ElectroacupunctureOlanzapine-contained Four-drug AntiemeticNausea and Vomiting
Jiuda Zhao 370
Post-approval studies (Phase 4)Study completedNCT00331825
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Who this might be right for
SchizophreniaExtrapyramidal Syndrome
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70
Large-scale testing (Phase 3)Study completedNCT00259272
What this trial is testing

Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine

Who this might be right for
Bipolar Disorder I or II
Eli Lilly and Company 141
Post-approval studies (Phase 4)Study completedNCT00394095
What this trial is testing

Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine

Who this might be right for
Bipolar DisorderWeight Gain
University of Cincinnati 31
Not applicableLooking for participantsNCT07263191
What this trial is testing

Olanzapine in Participants With Bipolar Disorder.

Who this might be right for
Bipolar Disorder
Boryung Pharmaceutical Co., Ltd 3,000
Post-approval studies (Phase 4)Study completedNCT00845507
What this trial is testing

Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

Who this might be right for
Weight Gain
University of Cincinnati 54
Not applicableEnded earlyNCT00203307
What this trial is testing

A Research Study Examining the Use of Olanzapine for the Prevention of Migraine

Who this might be right for
Migraine
Thomas Jefferson University 3
Post-approval studies (Phase 4)Study completedNCT01864551
What this trial is testing

Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder

Who this might be right for
Bipolar Disorder
Tri-Service General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01903837
What this trial is testing

ALKS 3831 in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 347
Large-scale testing (Phase 3)Study completedNCT00159783
What this trial is testing

40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857)

Who this might be right for
Bipolar Disorder
Organon and Co 218
Post-approval studies (Phase 4)Study completedNCT00324051
What this trial is testing

Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet

Who this might be right for
Schizophrenia
Eli Lilly and Company 284
Testing effectiveness (Phase 2)Study completedNCT03818256
What this trial is testing

Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications

Who this might be right for
Antipsychotic-induced Weight Gain (AIWG)
Corcept Therapeutics 71
Post-approval studies (Phase 4)Study completedNCT01164059
What this trial is testing

Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

Who this might be right for
Schizophrenia
University of Bremen 149
Post-approval studies (Phase 4)Study completedNCT01920802
What this trial is testing

Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo

Who this might be right for
Healthy
New York State Psychiatric Institute 31
Testing effectiveness (Phase 2)WithdrawnNCT02538081
What this trial is testing

Nicotinic Receptors and Schizophrenia

Who this might be right for
Schizophrenia
VA Office of Research and Development
Large-scale testing (Phase 3)Ended earlyNCT00124930
What this trial is testing

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

Who this might be right for
NauseaNeoplasms
Alberta Health services 80
Post-approval studies (Phase 4)Study completedNCT00190892
What this trial is testing

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 120
Post-approval studies (Phase 4)Study completedNCT01303601
What this trial is testing

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

Who this might be right for
Bipolar DisorderDepression, Bipolar
China Medical University, China 68
Load More Results